Author

Ehab Bakbak

Observed names: Bakbak, Ehab, E Bakbak, E. Bakbak, EHAB BAKBAK

Institution: The University of Queensland

Observed institutions: St. Michael's Hospital, The University of Queensland, University of Toronto, Unity Health Toronto

ORCID: 0000-0003-4687-6553

Observed ORCID: 0000-0003-4687-6553

OpenAlex ID: A5057485405

GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage

2024 · Brady Park, Ehab Bakbak, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 104

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

2022 · Kim A. Connelly, C. David Mazer, et al. · Circulation · 35

PDF

Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?

2021 · Ehab Bakbak, Daniella C. Terenzi, et al. · Reviews in Endocrine and Metabolic Disorders · 30

Vascular repair and regeneration in cardiometabolic diseases

2021 · David A Hess, Subodh Verma, et al. · European Heart Journal · 29

GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes

2024 · Brady Park, Aishwarya Krishnaraj, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 19

Vascular Regenerative Cell Deficiencies in South Asian Adults

2024 · Aishwarya Krishnaraj, Ehab Bakbak, et al. · Journal of the American College of Cardiology · 18

Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling

2023 · Ehab Bakbak, Subodh Verma, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 16

Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity

2023 · Daniella C Terenzi, Ehab Bakbak, et al. · Cardiovascular Research · 13

PDF

Isolation and characterization of circulating pro-vascular progenitor cell subsets from human whole blood samples

2021 · Daniella C. Terenzi, Ehab Bakbak, et al. · STAR Protocols · 11

PDF

Semaglutide promotes bone marrow–derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial

2025 · Brady Park, Fallon Dennis, et al. · European Heart Journal · 10

PDF

Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial

2024 · Ehab Bakbak, Aishwarya Krishnaraj, et al. · Med · 9

Vascular regenerative cells in cardiometabolic disease

2023 · Ehab Bakbak, Aishwarya Krishnaraj, et al. · Current Opinion in Cardiology · 7

Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease

2023 · Aishwarya Krishnaraj, Ehab Bakbak, et al. · Med · 4

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial

2023 · William Barbour, Erika Wolff, et al. · BMC Cardiovascular Disorders · 3

PDF

Regenerative Cell Exhaustion and Cardiovascular Risk in South Asians: a Pilot Study

2023 · Aishwarya Krishnaraj, Ehab Bakbak, et al. · Journal of the American College of Cardiology · 1

Empagliflozin Reduced Circulating Pro-inflammatory Precursor Cell Content in People Without Diabetes: a Substudy of the Empa-heart 2 Cardiolink 6 Trial

2023 · Ehab Bakbak, Pankaj Puar, et al. · Journal of the American College of Cardiology · 1

P015 Impairment in Vascular Regenerative and Reparative Cell Flux in South Asians: a Novel Mechanism of Enhanced Atherosclerotic Risk

2025 · S. Hassan, A. Krishnaraj, et al. · Canadian Journal of Cardiology

Effects of Icosapent Ethyl on Vascular Regenerative Cells in Individuals With Elevated Triglycerides: Insights From the Ipe-prevention Cardiolink-14 Trial

2024 · E. Bakbak, A. Krishnaraj, et al. · Canadian Journal of Cardiology

755-P: GLP-1RA Therapy Recovers Vascular Regenerative Cell Content in High Cardiovascular–Risk Individuals with Type 2 Diabetes

2024 · AISHWARYA KRISHNARAJ, BRADY PARK, et al. · Diabetes

Assessing the Impact of Cardioprotective Therapies on Vascular Regenerative Cell Content in People at Risk for Adverse Cardiovascular Events

2024 · Bakbak, Ehab · TSpace (University of Toronto)

PDF

Effects of Icosapent Ethyl on Vascular Regenerative Cells in Individuals With Elevated Triglycerides: Insights From the Ipe-prevention Cardiolink-14 Trial

2024 · Ehab Bakbak, Aishwarya Krishnaraj, et al. · Journal of the American College of Cardiology

South Asian adults with ASCVD exhibit a reduction in circulating vascular regenerative cell content compared to White European adults: a sub-analysis of the ORIGINS-RCE CardioLink-13 study

2023 · A Krishnaraj, E Bakbak, et al. · European Heart Journal

PDF

Glomerular filtration rate predicts pro-vascular progenitor cell depletion: insights from the IPE-PREVENTION and ORIGINS-RCE studies

2023 · E Bakbak, A Krishnaraj, et al. · European Heart Journal

PDF

Empagliflozin Improves Vascular Regenerative Cell Content in People Without Diabetes

2023 · E. Bakbak, S. Verma, et al. · Canadian Journal of Diabetes

Glp-1ra Therapy Is Associated With Higher Vascular Regenerative Cell Content and Lower Inflammatory Burden in People Living With Type 2 Diabetes

2023 · A. Krishnaraj, B. Park, et al. · Canadian Journal of Diabetes

Works count: 33

Citation count: 309

H-index: 10

I10-index: 10